Your browser doesn't support javascript.
loading
The miR-145-MMP1 axis is a critical regulator for imiquimod-induced cancer stemness and chemoresistance.
Zhu, Shan; Yang, Ning; Niu, Chao; Wang, Wan; Wang, Xue; Bai, Junge; Qiao, Yuan; Deng, Shuanglin; Guan, Yi; Chen, Jingtao.
Afiliação
  • Zhu S; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China.
  • Yang N; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China.
  • Niu C; Department of Cancer Center, The First Hospital of Jilin University, Changchun 130024, China.
  • Wang W; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China.
  • Wang X; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China.
  • Bai J; Department of Colorectal Surgery, The Forth Affiliated Hospital of Harbin Medical University, Harbin 150040, China.
  • Qiao Y; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China.
  • Deng S; Department of Neurosurgery, The First Hospital of Jilin University, Changchun 130024, China.
  • Guan Y; Department of Neurosurgery, The First Hospital of Jilin University, Changchun 130024, China.
  • Chen J; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, China. Electronic address: jtchen@jlu.edu.cn.
Pharmacol Res ; 179: 106196, 2022 05.
Article em En | MEDLINE | ID: mdl-35358680
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article